Introduction
Species similarities and differences for metabolic clearance of drug candidates are important issues for drug development. For predicting human toxicokinetic and pharmacokinetic profiles of drug candidates, non-human primates have been used because of their physiological and genetic similarity to humans (Orsi et al., 2011; Sasaki, 2015) .
Common marmosets (Callithrix jacchus), small New World Monkeys, are useful non-human primate species for preclinical testing due to their functional similarity of cytochrome P450 (P450) enzymes to those of humans . Recently, our studies demonstrated similar enzymatic properties of P450 3A and 2D enzymes (Uehara et al., 2015a; 2017b) .
Metoprolol is a β-adrenergic blocking drug used in cardiovascular medicine. Racemic mixtures of metoprolol have been used for treating hypertension, angina pectoris, and arrhythmia, but the pharmacological effects reside in the S-enantiomer of metoprolol (Lennard et al., 1986) . Metoprolol is metabolized through O-demethylation (65% of dose), α-hydroxylation (10% of dose), and N-dealkylation (10% of dose) in humans in vivo (Borg et al., 1975) . The α-hydroxylation of metoprolol is catalyzed almost entirely, and O-demethylation of metoprolol catalyzed partially, through human P450 2D6 (Otton et al., 1988) . Reportedly, human P450 2D6 preferentially catalyzed the R-enantiomer, faster than the S-enantiomer (Mautz et al., 1995) . In our recent studies, marmoset P450 2D6 and 2D8 enzymes catalyzed metoprolol O-demethylation (Uehara et al., 2015a) indicating that the roles of marmoset P450 enzymes in metoprolol metabolism need to be further elucidated for preclinical studies. In this study, the role of P450s for regio-and stereo-selective metoprolol oxidations were evaluated in marmosets and humans. We report herein the high affinity of marmoset P450 2D enzymes with R-metoprolol O-demethylation and the high capacity of marmoset P450 3A enzymes for R-and S-metoprolol O-demethylation.
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Materials and Methods
Detailed methods are shown separately in the Supplemental Data. Pooled liver microsomes from mice (CD-1, 8 males, aged 11 weeks), rats (Sprague-Dawley, 3 males), minipigs (Gottingen, 2 males, aged 7 months), dogs (10 males, aged >12 months), marmosets (5 males, sexually mature), and humans (74 males and 76 females, aged 18-82 years) were purchased from Corning Life Sciences (Woburn, MA). Pooled liver microsomes from cynomolgus monkeys (5 males, sexually mature) were purchased from Xenotech (Lenexa, KS). Liver microsomes from 17 individual human subjects were obtained from Corning Life Sciences. Individual liver microsomes were prepared from 23 marmosets (14 males and 9 females, aged >2 years) at the Central Institution for Experimental Animals (Kawasaki, Japan) in our laboratory as described previously (Uehara et al., 2017a) . This study was reviewed and approved by the Institutional Animal Care and Use Committee (Central Institution for Experimental Animals).
Activities of metoprolol O-demethylation and α-hydroxylation by liver microsomes and recombinant P450s were measured as described previously (Uehara et al., 2015a) 
Results and Discussion
R-and S-metoprolol oxidation activities by liver microsomes from humans, cynomolgus monkeys, marmosets, minipigs, dogs, rats, and mice were determined at a substrate concentration of 1.0 μM (Fig. 1) . Rat liver microsomes preferentially catalyzed R-and S-metoprolol α-hydroxylations rather than O-demethylations, in contrast to slow rates of Rand S-metoprolol oxidations in mouse liver microsomes. On the other hand, cynomolgus monkey liver microsomes effectively catalyzed R-and S-metoprolol O-demethylations rather than α-hydroxylations. Human, marmoset, and minipig liver microsomes showed roughly similar regio-and stereo-selective R-and S-metoprolol oxidation activities under the present conditions. R-and S-metoprolol oxidation activities by human and marmoset recombinant P450 enzymes were determined at the substrate concentration of 10 μM (Supplemental Fig. 1 Kinetic analyses for O-demethylations and α-hydroxylations of R-and S-metoprolol were performed using liver microsomes from humans and marmosets and recombinant P450 enzymes (Supplemental Fig. 5 and other enzyme sources were high (over ~500 μM) under the present conditions.
Oral administrations of metoprolol in cynomolgus monkeys and minipigs yielded plasma concentrations similar to their quantitative detection limits (Mogi et al., 2012; Shida, et al., 2015) , suggesting rapid oxidative clearance of metoprolol in vivo in a similar manner to the in vitro oxidations in cynomolgus monkeys (Fig. 1) . At a high concentration of 100 µM (not at 1.0 µM in Fig. 1 ), metoprolol oxidations by minipig liver microsomal P450 2D25 were faster than human liver microsomal P450 2D6 (Mogi et al., 2012; Yamazaki, 2014) , resulting in low bioavailability of metoprolol after oral administration in minipigs. On the other hand, human plasma concentrations of P450 probes containing metoprolol can be reportedly extrapolated from the corresponding data in marmosets after oral administration using simplified physiologically based pharmacokinetic modeling with in vitro metabolic clearance data .
In this study, liver microsomes from humans and marmosets preferentially mediated (Fig. 1) , different from cynomolgus monkeys. Stereoselectivity for R-metoprolol O-demethylation by marmoset liver microsomes was efficiently mediated by liver microsomal P450 2D6, as shown in this study (Supplemental Fig. 1 and Table 1 ), similar to reported human P450 2D-dependent (Mautz et al., 1995) . The calculated Vmax/Km values for R-and S-metoprolol O-demethylations in liver microsomes from humans and marmosets were comparable (Table 1) , which showed stereoselective metoprolol O-demethylation in a similar manner to recombinant human and marmoset P450 2D6 enzymes (Supplemental Fig. 1) . The 
R-metoprolol O-demethylations rather than S-metoprolol O-demethylations
R-metoprolol O-demethylation
In terms of R-and S-metoprolol O-demethylation
activities by marmoset liver microsomes, the metabolite formation rate per mg protein was high, compared with those of human liver microsomes (Fig. 1) , possibly accounted for by marmoset P450 2D and 3A enzymes which equally contributed at low substrate concentrations as evident by the correlation analysis (Supplemental Figs. 2 and 3) . In this study, metabolite formation from R-and S-metoprolol in vitro elucidated P450 2D-dependent enantioselective metabolism in marmoset livers (Table 1) . Further study of plasma concentrations of metoprolol and the metabolites separately in marmosets in vivo would be of great interest.
Similarly, regio-and stereo-selective oxidation of a classical β-blocker propranolol in human, cynomolgus monkey, and marmoset livers have been investigated (Narimatsu et al., 2011) . Propranolol enantiomers were S-enantiomer-stereoselectively oxidized by human P450 2D6, cynomolgus monkey P450 2D6 (2D17), and marmoset P450 2D6 enzymes mainly into 4-hydroxypropranolol, followed by 5-hydroxypropranolol and N-desisopropylpropranolol, but cynomolgus monkey P450 2D6 (2D17) had stronger high N-desisopropylpropranolol formation activity among these three primate P450 2D enzymes.
These results, together with the results in the present study, suggest similar regio-and stereo-selectivity of human and marmoset P450 2D6 enzymes.
Metoprolol pharmacokinetics in humans has been influenced by human P450 2D6
genotype groups (Blake et al., 2013) . There was a significant difference with nearly 40%
lower R-than S-metoprolol in plasma concentrations between ultra-rapid and extensive metabolizers having two active P450 2D6 alleles and two P450 2D6 null alleles (Blake et al., 2013) . Marmoset P450 enzymes show high sequence homology to their human counterparts and genetic polymorphisms have recently been found in marmoset P450 2C19 gene (Uehara et al., 2015b; 2016a) . However, we have not found marmoset P450 2D6
non-synonymous variants even after screening the genomes of nearly 80 individual marmosets by direct sequence analysis (Uehara, unpublished data) . If marmoset P450 2D6
variants might change the enzyme properties like marmoset P450 2C19 (Uehara et al., 2015b; , marmosets harboring genetic variant(s) would be suitable models for enantioselective drug metabolism associated with polymorphic P450 2D enzyme in livers.
In conclusion, metoprolol oxidation activities were evaluated with respect to regio-and stereo-selective R-and S-metoprolol O-demethylations in humans and marmosets. The high affinities of human and marmoset P450 2D6 enzymes with respect to R-metoprolol O-demethylations and the capacities of marmoset liver microsomal P450 3A enzymes for Rand S-metoprolol O-demethylation were observed. The present results demonstrated that the major roles of marmoset liver microsomal P450 2D6 enzymes for the regio-and stereo-selective metoprolol oxidation were similar to human P450 2D6, but the minor roles of P450 3A enzymes were unique to marmosets. Therefore, marmosets may be a good model for P450 2D-dependent regio-and enantio-selective drug metabolism in preclinical studies.
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